Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo.

Abstract:

:Pancreatic cancer (PC) is one of the leading causes of cancer-related deaths worldwide. Frequent metastasis and recurrence are the main reasons for the poor prognosis of PC patients. Thus, the discovery of new biomarkers and wider insights into the mechanisms involved in pancreatic tumorigenesis and metastasis is crucial. In the present study, we report that leukemia inhibitory factor receptor (LIFR) suppresses tumorigenesis and metastasis of PC cells both in vitro and in vivo. LIFR expression was significantly lower in PC tissues and was associated with local invasion (P=0.047), lymph node metastasis (P=0.014) and tumor-node-metastasis (TNM) stage (P=0.002). Overexpression of LIFR significantly suppressed PC cell colony formation (P=0.005), migration (P=0.003), invasion (P=0.010) and wound healing ability (P=0.013) in vitro, while opposing results were observed after LIFR was silenced. Furthermore, animal xenograft and metastasis models confirm that the in vivo results were consistent with the outcomes in vitro. Meanwhile, LIFR inhibited the expression of β-catenin, vimentin and slug and induced the expression of E-cadherin, suggesting that the epithelial-mesenchymal transition regulation pathway may underlie the mechanism. These results indicate that LIFR negatively regulates the metastasis of PC cells.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Ma D,Jing X,Shen B,Liu X,Cheng X,Wang B,Fu Z,Peng C,Qiu W

doi

10.3892/or.2016.4865

subject

Has Abstract

pub_date

2016-08-01 00:00:00

pages

827-36

issue

2

eissn

1021-335X

issn

1791-2431

journal_volume

36

pub_type

杂志文章
  • Expression of HIF-1alpha and Glut-1 in human bladder cancer.

    abstract::HIF-1 is a heterodimer consisting of the HIF-1alpha and HIF-1beta subunits, and HIF-1alpha is the unique oxygen regulated subunit that determines HIF-1 activity. HIF-1alpha upgrades many gene products which include the glucose transporter protein 1 (Glut-1). Immunohistochemical studies using a monoclonal antibody spec...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.14.4.909

    authors: Palit V,Phillips RM,Puri R,Shah T,Bibby MC

    更新日期:2005-10-01 00:00:00

  • 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts.

    abstract::We investigated whether 18F-fluorothymidine-positron-emission tomography/computed tomography (18F-FLT-PET/CT) is useful for the evaluation of the very early response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab therapy in human lung cancer xenografts. A human tumor xenograft model was established...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1338

    authors: Takeuchi S,Zhao S,Kuge Y,Zhao Y,Nishijima K,Hatano T,Shimizu Y,Kinoshita I,Tamaki N,Dosaka-Akita H

    更新日期:2011-09-01 00:00:00

  • Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins.

    abstract::MAP kinase signaling proteins have major implications in the molecular oncogenesis of breast cancers and have been extensively investigated as putative targets for therapy. This study reports the investigation of the expression of P38 MAPK and its phosphorylated form (p-P38 MAPK) in clinical specimens of invasive brea...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2645

    authors: Merlin JL,Harlé A,Lion M,Ramacci C,Leroux A

    更新日期:2013-10-01 00:00:00

  • Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma.

    abstract::The purpose of this study was to define gene expression profile changes in colorectal tumors in order to identify target genes involved in neoplastic progression. cDNA microarray analysis was used to detect differences in gene expression profiles between colon tumor samples obtained from 20 patients in different tumor...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Bandres E,Catalan V,Sola I,Honorato B,Cubedo E,Cordeu L,Andion E,Escalada A,Zarate R,Salgado E,Zabalegui N,García F,Garcia-Foncillas J

    更新日期:2004-08-01 00:00:00

  • Endocannabinoid and ceramide levels are altered in patients with colorectal cancer.

    abstract::Endocannabinoids and ceramides have demonstrated growth inhibition, cell death induction and pro-apoptotic activity in cancer research. In the present study, we describe the profiles of two major endocannabinoids, ceramides, free fatty acids and relevant metabolic enzymes in 47 pairs of human colorectal cancer tissues...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3973

    authors: Chen L,Chen H,Li Y,Li L,Qiu Y,Ren J

    更新日期:2015-07-01 00:00:00

  • Role of triosephosphate isomerase and downstream functional genes on gastric cancer.

    abstract::Triosephosphate isomerase (TPI) is highly expressed in many types of human tumors and is involved in migration and invasion of cancer cells. However, TPI clinicopathological significance and malignant function in gastric cancer (GC) have not been well defined. The present study aimed to examine TPI expression in GC ti...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5846

    authors: Chen T,Huang Z,Tian Y,Wang H,Ouyang P,Chen H,Wu L,Lin B,He R

    更新日期:2017-09-01 00:00:00

  • JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.

    abstract::Recent research indicates that the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) pathway may play an important role in chronic inflammation which promotes cancer progression, yet the mechanism is not clear. The present study aimed to investigate the role of the JAK/STAT3 pathway in the gr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3609

    authors: Fang J,Chu L,Li C,Chen Y,Hu F,Zhang X,Zhao H,Liu Z,Xu Q

    更新日期:2015-01-01 00:00:00

  • Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.

    abstract::The p16 protein is a cyclin-dependent kinase (CDK) inhibitor, which plays an important role in the regulation of the cell cycle by inactivating the cyclin-dependent kinase (CDK) that phosphorylates the retinoblastoma (Rb) protein. Overexpression of p16 protein has been found in many types of human malignancy. Autoanti...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Looi K,Megliorino R,Shi FD,Peng XX,Chen Y,Zhang JY

    更新日期:2006-11-01 00:00:00

  • Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer.

    abstract::The present study was carried out to investigate the clinical significance of TMPRSS3 and TNFRSF11B in breast cancer. Thus, the expression levels of TMPRSS3 and TNFRSF11B and the correlation with prognosis in patients with breast cancer were analyzed in silico using gene microarray and hierarchical clustering analysis...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5449

    authors: Luo P,Lu G,Fan LL,Zhong X,Yang H,Xie R,Lv Z,Lv QZ,Fu D,Yang LX,Ma Y

    更新日期:2017-04-01 00:00:00

  • Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.

    abstract::In preclinical studies, antagonists of growth hormone-releasing hormone (GHRH) have demonstrated inhibitory effects on the growth of various types of cancers expressing the pituitary type of GHRH receptors (pGHRH-R) and/or its active splice variant 1 (SV1). In this study, we investigated the effectiveness of the treat...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2435

    authors: Seitz S,Rick FG,Schally AV,Treszl A,Hohla F,Szalontay L,Zarandi M,Ortmann O,Engel JB,Buchholz S

    更新日期:2013-07-01 00:00:00

  • The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.

    abstract::To investigate the antitumor action of arsenic trioxide (As2O3) by intratumoral injection into solid tumors, tumor growth inhibition (TGI) and angiogenesis of heterotransplanted esophageal carcinoma in mice was carried out. The cultured human esophageal carcinoma cells were inoculated into both laterals of the abdomin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Shen ZY,Shen J,Chen MH,Wu XY,Wu MH,Zeng Y

    更新日期:2003-11-01 00:00:00

  • Characterization of the prostaglandin biosynthetic pathway in non-small cell lung cancer: a comparison with small cell lung cancer and correlation with angiogenesis, angiogenic factors and metastases.

    abstract::To investigate the components of the prostaglandin biosynthetic pathway, the characteristics of cyclooxygenase (COX)-1, COX-2, hematopoietic prostaglandin D synthase (hPGDS), microsomal prostaglandin E synthase (mPGES), and thromboxane synthase (TXS) were examined for autopsied cases with small cell lung cancer (SCLC)...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yoshimoto A,Kasahara K,Kawashima A,Fujimura M,Nakao S

    更新日期:2005-06-01 00:00:00

  • Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.

    abstract::Ribonucleotide reductase M2 subunit (RRM2) is one of the two subunits of human ribonucleotide reductase which plays a critical role in tumor progression. The aim of the present study was to analyze its expression, clinical significance and biological functions in gastric adenocarcinoma. We observed the upregulation of...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3148

    authors: Kang W,Tong JH,Chan AW,Zhao J,Wang S,Dong Y,Sin FM,Yeung S,Cheng AS,Yu J,To K

    更新日期:2014-06-01 00:00:00

  • Induction of eEF2-specific antitumor CTL responses in vivo by vaccination with eEF2-derived 9mer-peptides.

    abstract::Eukaryotic elongation factor 2 (eEF2) is an essential factor for protein synthesis. Previous studies have shown that the eEF2 gene was overexpressed and plays an oncogenic role in various types of cancers and that eEF2 gene product elicited both humoral immune responses to produce eEF2-specific IgG autoantibody in can...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4589

    authors: Nakajima H,Murakami Y,Morii E,Akao T,Tatsumi N,Odajima S,Fukuda M,Machitani T,Iwai M,Kawata S,Hojo N,Oka Y,Sugiyama H,Oji Y

    更新日期:2016-04-01 00:00:00

  • The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.

    abstract::Human glioblastoma is a malignant and aggressive primary human brain solid tumor characterized by severe hypoxia. Hypoxia can induce autophagy, which may result in chemoresistance and malignant progression of cancer cells. MicroRNAs (miRNAs) have been reported to modulate hypoxia‑induced autophagy in various types of ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6929

    authors: Huang S,Qi P,Zhang T,Li F,He X

    更新日期:2019-03-01 00:00:00

  • Diagnostic and therapeutic role of microRNAs in oral cancer (Review).

    abstract::Oral cancer is one of the leading types of cancer and remains the most common cause of cancer‑related mortality in Asia. The pathogenesis of oral cancer is complicated and, due to lack of accurate diagnostic methods and efficient treatment strategies, oral cancer is responsible for a large number of deaths. Therefore,...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7854

    authors: Wang J,Lv N,Lu X,Yuan R,Chen Z,Yu J

    更新日期:2021-01-01 00:00:00

  • Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.

    abstract::Pancreatic cancer is one of the most deadly carcinomas worldwide. Although gemcitabine as the standard chemotherapy agent has been proven to be effective, the response rate remains at 5.4% and the 5-year survival rate is extremely poor. Ursolic acid (UA) is a small molecule compound...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1827

    authors: Li J,Liang X,Yang X

    更新日期:2012-08-01 00:00:00

  • Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.

    abstract::Muscle atrophy F-Box (MAFbx)/atrogin-1 and muscle ring-finger-1 (MuRF-1) have been identified as two muscle-specific E3 ubiquitin ligases that are highly expressed in skeletal muscle during muscle atrophy. However, the role of muscle-specific E3 ubiquitin ligases during the process of muscle atrophy of cancer cachexia...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3845

    authors: Yuan L,Han J,Meng Q,Xi Q,Zhuang Q,Jiang Y,Han Y,Zhang B,Fang J,Wu G

    更新日期:2015-05-01 00:00:00

  • Quercetin-induced autophagy flux enhances TRAIL-mediated tumor cell death.

    abstract::Quercetin is a potent cancer therapeutic agent and dietary antioxidant present in fruit and vegetables. Quercetin prevents tumor proliferation by inducing cell cycle arrest and is a well known cancer therapeutic agent and autophagy mediator. We investigated whether quercetin enhances TRAIL-induced tumor cell death and...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3991

    authors: Moon JH,Eo SK,Lee JH,Park SY

    更新日期:2015-07-01 00:00:00

  • Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?

    abstract::The abilities of 5,6-benzoflavone (5,6-BF, a synthetic flavonoid), indole-3-carbinol (I3C, a plant derived product) or diindolylmethane (DIM, a condensation product of I3C) to alter the induction of mammary cancers induced by the carcinogens 7,12-dimethylbenzanthracene (DMBA) or N-methyl-N-nitrosourea (MNU) were evalu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1316

    authors: Lubet RA,Heckman BM,De Flora SL,Steele VE,Crowell JA,Juliana MM,Grubbs CJ

    更新日期:2011-09-01 00:00:00

  • Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.

    abstract::Inhibins are dimeric glycoproteins, composed of an α-subunit and one of two possible β-subunits (βA or βB), with substantial roles in human reproduction and in endocrine-responsive tumours. Recently a novel β subunit named βC was described, although it is still unclear if normal or cancerous cervical epithelial cells ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Blankenstein T,Jückstock J,Shabani N,Kunze S,Brüning A,Bergauer F,Mylonas I

    更新日期:2011-01-01 00:00:00

  • Caspase-dependent mitochondrial apoptotic pathway is involved in astilbin-mediated cytotoxicity in breast carcinoma cells.

    abstract::Astilbin exhibits several pharmacological activities, including hypoglycemic, anti-oxidant and anti-inflammatory properties. The aim of the present study was to investigate the pro-apoptotic activities of astilbin on breast cancer in cells and mice. It was demonstrated that astilbin significantly reduced the cell viab...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6602

    authors: Sun X,Zhang H,Zhang Y,Yang Q,Zhao S

    更新日期:2018-10-01 00:00:00

  • Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.

    abstract::Lung cancer is still the leading cause of cancer-related deaths worldwide. Identifying new oncogenic drivers and developing efficient inhibitors through molecular targeting approaches are crucial for improving therapies. The aim of this study was to investigate whether targeting fibroblast growth factor receptor 1 (FG...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2386

    authors: Ren M,Hong M,Liu G,Wang H,Patel V,Biddinger P,Silva J,Cowell J,Hao Z

    更新日期:2013-06-01 00:00:00

  • HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells.

    abstract::Many prostate cancer (PCa) patients die of recurrent disease due to the emergence of hormone-independent cancer cells of which the mechanism is not fully understood. Our previous studies demonstrated that most castration- resistant prostate cancers (CRPC) overexpress the HOXB13 transcription factor to confer positive ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4563

    authors: Kim YR,Kang TW,To PK,Xuan Nguyen NT,Cho YS,Jung C,Kim MS

    更新日期:2016-04-01 00:00:00

  • Lack of prognostic significance of nm23 expression in human primary breast cancer.

    abstract::This retrospective study was designed to evaluate the prognostic value of immunohistochemically detected nm23-expression in invasive breast cancer. Cellular expression of nm23 was assessed in 325 primary breast cancer tissues by immunohistochemistry. The data were correlated to established functional factors of progno...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Göhring UJ,Eustermann I,Becker M,Neuhaus W,Rein DT,Schöndorf T

    更新日期:2002-11-01 00:00:00

  • Vimentin expression is associated with decreased survival in gastric cancer.

    abstract::Gastric cancer rich in stromal tissue, such as diffuse-type disease, carries a poor prognosis. In some cancers, expression of vimentin, a mesenchymal maker, is associated with poor survival. The expression of mesenchymal markers such as vimentin is observed after epithelial-mesenchymal transition (EMT), an important i...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1185

    authors: Otsuki S,Inokuchi M,Enjoji M,Ishikawa T,Takagi Y,Kato K,Yamada H,Kojima K,Sugihara K

    更新日期:2011-05-01 00:00:00

  • 5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines.

    abstract::Hepatocellular carcinoma (HCC) and pancreatic cancer are at the forefront of chemotherapy-resistant tumors with poor prognosis. Even with innovative treatment regimens, response rates remain low and the duration of response is short. We examined whether the suppression of DNA methylation was capable of enhancing the s...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kanda T,Tada M,Imazeki F,Yokosuka O,Nagao K,Saisho H

    更新日期:2005-10-01 00:00:00

  • Co-expression of FOXL1 and PP2A inhibits proliferation inducing apoptosis in pancreatic cancer cells via promoting TRAIL and reducing phosphorylated MYC.

    abstract::Pancreatic cancer is usually diagnosed in the advanced stages and is sensitive to only few therapies. The forkhead box L1 (FOXL1) and protein phosphatase 2A (PP2A) have been recognized to be tumor suppressive in human pancreatic cancers. In the present study, we co-expressed the two tumor suppressive molecules with a ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4592

    authors: Li Y,Yu D,Sheng W,Song H,Li Y,Dong M

    更新日期:2016-04-01 00:00:00

  • A novel region of deletion on 13q33-q34 in esophageal squamous cell carcinoma.

    abstract::Chromosome 13 presents frequent allelic loss in esophageal squamous cell carcinomas (ESCC). However, no ESCC suppressor gene has been identified from this chromosome. To define common deletion regions that possibly contain the ESCC suppressor gene(s), we performed a mapping of allelic loss in 50 esophageal squamous ce...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Guo GM,Huang XP,Dong JT,Caia Y,Xu X,Han YL,Wu M,Zhan QM,Wang MR

    更新日期:2005-12-01 00:00:00

  • Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells.

    abstract::The mammalian target of rapamycin (mTOR) is a key kinase acting downstream of growth factor receptor PI3K and AKT signaling, leading to processes resulting in increased cell size and proliferation through translation control. Rapamycin, a specific inhibitor of mTOR, results predomin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1855

    authors: Miyake N,Chikumi H,Takata M,Nakamoto M,Igishi T,Shimizu E

    更新日期:2012-09-01 00:00:00